InsidersTradesSigma
Explore the complete record of transactions filed by Skovronsky Daniel, Director. Officer active across 2 companies, notably Myriad Genetics INC. Aggregated, 7 reports have been published. The latest transaction was disclosed on 2 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
7 of 7 declarations
Daniel Skovronsky serves as a Director and Senior Vice President at Myriad Genetics Inc and Eli Lilly & Co. In this role, he participates in the governance of the companies and strategic decision-making. His experience in the biopharmaceutical sector allows him to make significant contributions to board discussions, ensuring that the companies remain aligned with their growth objectives.